Abstract

The metabolic checkpoint kinase mechanistic/mammalian target of rapamycin (mTOR) regulates natural killer (NK) cell development and function, but the exact underlying mechanisms remain unclear. Here, we show, via conditional deletion of Raptor (mTORC1) or Rictor (mTORC2), that mTORC1 and mTORC2 promote NK cell maturation in a cooperative and non-redundant manner, mainly by controlling the expression of Tbx21 and Eomes. Intriguingly, mTORC1 and mTORC2 regulate cytolytic function in an opposing way, exhibiting promoting and inhibitory effects on the anti-tumor ability and metabolism, respectively. mTORC1 sustains mTORC2 activity by maintaining CD122-mediated IL-15 signaling, whereas mTORC2 represses mTORC1-modulated NK cell effector functions by restraining STAT5-mediated SLC7A5 expression. These positive and negative crosstalks between mTORC1 and mTORC2 signaling thus variegate the magnitudes and kinetics of NK cell activation, and help define a paradigm for the modulation of NK maturation and effector functions.

Details

Title
Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function
Author
Wang, Fangjie 1 ; Meng, Meng 1 ; Mo, Banghui 1 ; Yang, Yao 1 ; Ji, Yan 1 ; Huang, Pei 1 ; Lai, Wenjing 1 ; Pan, Xiaodong 1 ; You, Tingting 1 ; Luo, Hongqin 1 ; Guan, Xiao 1 ; Deng, Yafei 1 ; Yuan, Shunzong 2 ; Chu, Jianhong 3 ; Namaka, Michael 4 ; Hughes, Tiffany 5 ; Ye, Lilin 6 ; Yu, Jianhua 7   VIAFID ORCID Logo  ; Li, Xiaohui 1   VIAFID ORCID Logo  ; Deng, Youcai 1   VIAFID ORCID Logo 

 Institute of Materia Medica, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China 
 Department of Laboratory Medicine, PLA 307 Hospital, Beijing, China 
 Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, China 
 Institute of Materia Medica, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China; Colleges of Pharmacy and Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada 
 The Ohio State University Comprehensive Cancer Center and the James Cancer Hospital, Columbus, OH, USA 
 Institute of Immunology, Army Medical University (Third Military Medical University), Chongqing, China 
 The Ohio State University Comprehensive Cancer Center and the James Cancer Hospital, Columbus, OH, USA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA 
Pages
1-17
Publication year
2018
Publication date
Nov 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2135622509
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.